Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8655 USD | -3.27% | -8.11% | -42.68% |
Mar. 14 | Opko Health Insider Bought Shares Worth $444,300, According to a Recent SEC Filing | MT |
Mar. 13 | Opko Health Insider Bought Shares Worth $463,750, According to a Recent SEC Filing | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-42.68% | 624M | C | ||
-0.26% | 4.02B | B- | ||
+28.93% | 3.28B | C+ | ||
+1.23% | 2.82B | - | ||
-23.46% | 2.03B | B- | ||
-10.07% | 1.87B | C- | ||
-16.63% | 1.65B | C+ | ||
-16.57% | 1.63B | A- | ||
-11.04% | 1.13B | - | - | |
-5.38% | 985M | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock OPKO Health, Inc. - Nasdaq
- Ratings OPKO Health, Inc.